** = Publications listed in SCI/SSCI/Pubmed
** Damulina, A; Opriessnig, P; Pirpamer, L; Demjaha, R; Tafrali, C; Martinez-Serrat, M; Hofer, E; Wurth, S; Heschl, B; Hochmeister, S; Archelos, JJ; Pinter, D; Ropele, S; Enzinger, C; Khalil, M
Association of CSF Kappa-Free Light Chains With Cortical and Periventricular Brain Damage in Multiple Sclerosis.
Neurology. 2025; 105(12): e214433
Doi: 10.1212/WNL.0000000000214433
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Dargvainiene, J; Torge, A; Wandinger, KP; Junker, R; Markewitz, R; Benkert, P; Willemse, E; Maleska, A; Schuster, SO; Ziemann, M; Tafrali, C; Martinez-Serrat, M; Khalil, M; Kuhle, J; Leypoldt, F
Comparative analysis of three platforms for serum NfL quantification in healthy controls and MS patients.
Clin Chem Lab Med. 2025;
Doi: 10.1515/cclm-2025-1476
Web of Science
PubMed
FullText
FullText_MUG
** Gattermeyer-Kell, L; Khalil, M; Kern, D; Franthal, S; Katschnig-Winter, P; Kögl, M; Demjaha, R; Tafrali, C; Hofer, E; Schmidt, R; Enzinger, C; Schwingenschuh, P
Serum glial fibrillary acidic protein is elevated in early-stage late-onset essential tremor and associated with tremor progression.
J Neural Transm (Vienna). 2025; 132(8):1187-1195
Doi: 10.1007/s00702-025-02970-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Heim, B; Mandler, E; Peball, M; Carbone, F; Schwarzová, K; Demjaha, R; Tafrali, C; Buchmann, A; Khalil, M; Djamshidian, A; Seppi, K
Serum neurofilament light chain but not serum glial fibrillary acidic protein is a marker of early Huntington's disease.
J Neurol. 2025; 272(2): 174
Doi: 10.1007/s00415-025-12901-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rossini, F; Moser, T; Unterhofer, M; Khalil, M; Demjaha, R; Tafrali, C; Martinez-Serrat, M; Kuhle, J; Leppert, D; Benkert, P; Pfaff, JAR; Trinka, E; Pikija, S
Transient Global Amnesia (TGA): Is It Really Benign? A Pilot Study on Blood Biomarkers.
Int J Mol Sci. 2025; 26(6):
Doi: 10.3390/ijms26062629
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Datta, G; Martinez-Serrat, M; Tafrali, C; Demjaha, R; Pinter, D; Heschl, B; Damulina, A; Hofer, E; Ropele, S; Enzinger, C; McCurdy, S; Ruiz, L; Sheng, E; Hari, A; Tiwari, S; Hu, W; Brazel, D; Qureshi, F; Khalil, M
Characterizing MSDA Score and MSDA Panel Biomarker Associations with Disease Activity and Progression Measures in the Graz MS Study
MULT SCLER J. 2025; 31(3):326-326.-ECTRIMS 2025; SEP 24-26, 2025; Barcelona, SPAIN.
[Poster]
Web of Science
** Demjaha, R; Seiler, S; Hofer, E; Tafrali, C; Mart nez-Serrat, M; Pirpamer, L; Opriessnig, P; Ropele, S; Pinter, D; Hechenberger, S; Helmlinger, B; Leppert, D; Benkert, P; Kuhle, J; Enzinger, C; Schmidt, R; Khalil, M
Age-related dynamics of GFAP blood levels in normal ageing: Implications for biomarker studies in neurological diseases
EUR J NEUROL. 2025; 32:
Web of Science
** Ellmeier, E; Schnabl, A; Meissel, J; Stracke, A; Rittchen, S; Stöger, L; Tafrali, C; Demjaha, R; Martinez-Serrat, M; Kaiser, T; Zeiler, LC; Seifried, K; Topler, A; Klemen, I; Heschl, B; Damulina, A; Runtsch, MC; Fessler, J; Hofer, E; Khalil, M; Angiari, S
Targeting pyruvate kinase M2 (PKM2) reduces T cell pathogenicity in multiple sclerosis
MULT SCLER J. 2025; 31(3): 971-971.
Web of Science
** Gattermeyer-Kell, L; Khalil, M; Kern, D; Franthal, S; Katschnig-Winter, P; Koegl, M; Demjaha, R; Tafrali, C; Hofer, E; Schmidt, R; Enzinger, C; Schwingenschuh, P
sGFAP is elevated in essential tremor patients with late disease onset and short disease duration
EUR J NEUROL. 2025; 32:
Web of Science
** Helmlinger, B; Hechenberger, S; Jordan, S; Marschik, P; Trafali, C; Martinez-Serrat, M; Demjaha, R; Wurth, S; Damulina, A; Heschl, B; Khalil, M; Enzinger, C; Pinter, D
Motor Fatigue in Multiple Sclerosis: The Distinct Role of Motor and Psychological Factors
MULT SCLER J. 2025; 31(3): 827-828.
[Poster]
Web of Science
** Liutkevych, K; Helmlinger, B; Hechenberger, S; Jordan, S; Heschl, B; Damulina, A; Demjaha, R; Tafrali, C; Martinez-Serrat, M; Khalil, M; Enzinger, C; Pinter, D
Factors associated with fatigue and fatigue worsening in multiple sclerosis
MULT SCLER J. 2025; 31(3): 164-165.
[Poster]
Web of Science
** Mart nez-Serrat, M; Tafrali, C; Demjaha, R; Kaiser, T; Hofer, E; Ropele, S; Heschl, B; Wurth, S; Damulina, A; Pinter, D; Leppert, D; Benkert, P; Kuhle, J
Temporal dynamics of serum neurofilament light chain in MS: A retrospective study in a clinical routine setting
EUR J NEUROL. 2025; 32:
[Oral Communication]
Web of Science
** Martinez-Serrat, M; Datta, G; Tafrali, C; Demjaha, R; Helmlinger, B; Kaiser, T; Pinter, D; Heschl, B; Damulina, A; Hofer, E; Ropele, S; Enzinger, C; Brazel, D; Qureshi, F; Khalil, M
Temporal Dynamics of Proteomic Profiling in Multiple Sclerosis: Insights from a Retrospective Longitudinal Study
MULT SCLER J. 2025; 31(3): 306-307.
Web of Science
** Martinez-Serrat, M; Tafrali, C; Demjaha, R; Helmlinger, B; Kaiser, T; Hofer, E; Ropele, S; Heschl, B; Damulina, A; Leppert, D; Benkert, P; Kuhle, J; Enzinger, C; Khalil, M
Assessing the Role of Glial Fibrillary Acidic Protein in Combination with Neurofilament Light Chain for Multiple Sclerosis Disease Activity
MULT SCLER J. 2025; 31(3): 325-325.
[Poster]
Web of Science
** Martinez-Serrat, M; Tafrali, C; Demjaha, R; Helmlinger, B; Kaiser, T; Hofer, E; Ropele, S; Heschl, B; Damulina, A; Platos, E; Pinter, D; Leppert, D; Benkert, P; Kuhle, J; Enzinger, C; Khalil, M
Temporal Dynamics of Serum Neurofilament Light Chain in Multiple Sclerosis: A Retrospective Study in a Clinical Routine Setting
MULT SCLER J. 2025; 31(3): 310-311.
Web of Science
** Merseli, A; Haindl, MT; Hofer, E; Demjaha, R; Tafrali, C; Martinez-Serrat, M; Vittinghoff, K; Pinter, D; Enzinger, C; Lass, A; Khalil, M
The Implication of the Blood-Brain Barrier integrity on serum Neurofilament Light Chain levels as a marker for neuro-axonal injury
MULT SCLER J. 2025; 31(3): 763-764.
Web of Science
** Pinter, D; Jordan, S; Helmlinger, B; Hechenberger, S; Heschl, B; Damulina, A; Wurth, S; Demjaha, R; Tafrali, C; Martinez-Serrat, M; Khalil, M; Enzinger, C
Current versus chronic fatigue in people with multiple sclerosis and healthy controls - impact of cognition, sleep, anxiety and depression
MULT SCLER J. 2025; 31(3): 852-853.
[Poster]
Web of Science
** Tafrali, C; Martinez-Serrat, M; Demjaha, R; Buchmann, A; Hechenberger, S; Helmlinger, B; Opriessnig, P; Pinter, D; Damulina, A; Wurth, S; Heschl, B; Leppert, D; Benkert, P; Kuhle, J; Ropele, S; Enzinger, C; Khalil, M
Choroid plexus volume and serum neurofilament light levels in relation to brain atrophy and lesion load in MS
EUR J NEUROL. 2025; 32:
Web of Science
** Angiari, S; Carlucci, T; Budui, SL; Bach, SD; Dusi, S; Walter, J; Ellmeier, E; Schnabl, A; Stracke, A; Bordag, N; Tafrali, C; Demjaha, R; Khalil, M; Angelini, G; Terrabuio, E; Pietronigro, EC; Zenaro, E; Laudanna, C; Rossi, B; Constantin, G
Coenzyme A fueling with pantethine limits autoreactive T cell pathogenicity in experimental neuroinflammation.
J Neuroinflammation. 2024; 21(1): 287
Doi: 10.1186/s12974-024-03270-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Franthal, S; Khalil, M; Kern, D; Gattermeyer, L; Buchmann, A; Katschnig-Winter, P; Kögl, M; Demjaha, R; Tafrali, C; Hofer, E; Schmidt, R; Schwingenschuh, P
Elevated serum neurofilament light chain protein in patients with essential tremor.
Eur J Neurol. 2024; 31(2):e16143
Doi: 10.1111/ene.16143
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Haindl, MT; Üçal, M; Tafrali, C; Wonisch, W; Erdogan, C; Nowakowska, M; Adzemovic, MZ; Enzinger, C; Khalil, M; Hochmeister, S
Sex Differences under Vitamin D Supplementation in an Animal Model of Progressive Multiple Sclerosis.
Nutrients. 2024; 16(4):
Doi: 10.3390/nu16040554
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Queissner, R; Buchmann, A; Demjaha, R; Tafrali, C; Benkert, P; Kuhle, J; Jerkovic, A; Dalkner, N; Fellendorf, F; Birner, A; Platzer, M; Tmava-Berisha, A; Maget, A; Stross, T; Lenger, M; Häussl, A; Khalil, M; Reininghaus, E
Serum neurofilament light as a potential marker of illness duration in bipolar disorder.
J Affect Disord. 2024; 350:366-371
Doi: 10.1016/j.jad.2024.01.088
Web of Science
PubMed
FullText
FullText_MUG
** Demjaha, R; Seiler, S; Hofer, E; Tafrali, C; Pirpamer, L; Opriessnig, P; Ropele, S; Pinter, D; Hechenberger, S; Helmlinger, B; Leppert, D; Benkert, P; Kuhle, J; Enzinger, C; Schmidt, R; Khalil, M
Age-Related Dynamics of Glial Fibrillary Acidic Protein Blood Levels in a Normal Ageing Cohort: Implications for Biomarker Studies in Neurological Diseases
MULT SCLER J. 2024; 30(3):583-584.-40th ECTRIMS Congress; SEP 18-20, 2024; Copenhagen, DENMARK.
[Poster]
Web of Science
** Ellmeier, E; Carlucci, T; Budui, SL; Bach, SD; Dusi, S; Walter, J; Schnabl, A; Tafrali, C; Demjaha, R; Khalil, M; Bordag, N; Angelini, G; Terrabuio, E; Zenaro, E; Laudanna, C; Rossi, B; Constantin, G; Angiari, S
Coenzyme A fueling with pantethine limits autoreactive T cell pathogenicity in experimental neuroinflammation
EUR J IMMUNOL. 2024; 54: 401-401.-7th European Conference of Immunology; SEP 01-04, 2024; Dublin, IRELAND.
[Oral Communication]
Web of Science
** Schnabl, A; Ellmeier, E; Stracke, A; Seifried, K; Tafrali, C; Demjaha, R; Wurth, S; Khalil, M; Angiari, S
Targeting pyruvate kinase M2 to limit T cell pathogenicity in multiple sclerosis
EUR J IMMUNOL. 2024; 54: 74-74.-7th European Conference of Immunology; SEP 01-04, 2024; Dublin, IRELAND.
[Oral Communication]
Web of Science
** Damulina, A; Pirpamer, L; Demjaha, R; Tafrali, C; Wurth, S; Heschl, B; Hochmeister, S; Garcia, JJA; Opriessnig, P; Ropele, S; Enzinger, C; Khalil, M
Intrathecal kappa free light chains indicate higher MRI lesion burden in patients with multiple sclerosis
MULT SCLER J. 2023; 29: 565-565.
[Poster]
Web of Science
FullText